Cawkwell Gail 4
4 · Aclaris Therapeutics, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
Cawkwell Gail
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-07-01+210,000→ 210,000 totalExercise: $13.83Exp: 2032-06-30→ Common Stock (210,000 underlying) - Award
Restricted Stock Units
2022-07-01+60,000→ 60,000 total→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F3]The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.